Melania graduated with a Master’s degree in Medical Biotechnology from the University of Naples Federico II, Italy. Her Master’s research project focused on the use of the microbial transglutaminase enzymes as a biotechnology tool to modify the structure of allergens to reduce their allergenic potential.
She next secured a “Training Around” fellowship in order to travel to the Institute of Food Research (IFR) in Norwich. During the fellowship she used Atomic Force Microscopy to study the intra- and inter-molecular forces that occur in protein gel systems.
Upon completion of the fellowship she remained in Norwich working at the University of East Anglia (UEA) School of Pharmacy where she contributed to the development of a peptide-targeted liposomal drug carrier for the treatment of Small Cell Lung Cancer.
In 2013 Melania began her PhD studies on the intermolecular interactions between inhaled drug molecules and mucus. This work includes the use of in vitro biological barrier models, analytical chemistry and spectroscopic techniques for elucidating the nature of drug-mucin interactions.